Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D
查看IDENTITY
结构与身份
- 标准SMILES
- [Na+]
- InChIKey
- FKNQFGJONOIPTF-UHFFFAOYSA-N
- 分子式
- Na+
- 平均分子量
- 22.9898 g/mol
- 单同位素质量
- 22.98976928
COMPUTED
结构计算性质
- 极性表面积
- 0 Ų
- 氢键供体
- 0
- 氢键受体
- 0
- 可旋转键
- 0
- 重原子
- 1
- 形式电荷
- 1
- 复杂度
- 0
PROPERTIES
实验与物化性质
Melting Point
97.82 °C
Physical Description
Solid
PHARMACOLOGY
药理信息
FDA Pharmacological Classification
LYR4M0NH37
SODIUM CATION
Established Pharmacologic Class [EPC] - Osmotic Laxative
Physiologic Effects [PE] - Increased Large Intestinal Motility
Physiologic Effects [PE] - Inhibition Large Intestine Fluid/Electrolyte Absorption
Mechanisms of Action [MoA] - Osmotic Activity
Tissue Locations
Kidney
Cellular Locations
Extracellular;Golgi apparatus;Peroxisome
Metabolite Pathways
3-Methylthiofentanyl Action Pathway;Acebutolol Action Pathway;Alfentanil Action Pathway;Alprenolol Action Pathway;Alvimopan Action Pathway;Amiloride Action Pathway;Amiodarone Action Pathway;Amlodipine Action Pathway;Anileridine Action Pathway;Arbutamine Action Pathway;Total 139 pathways, visit the HMDB page for details
ALIASES
名称与别名
REACTIONS
参与反应
Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D
查看